UVIKTOS Trademark

Trademark Overview


On Friday, April 1, 2022, a trademark application was filed for UVIKTOS with the United States Patent and Trademark Office. The USPTO has given the UVIKTOS trademark a serial number of 97342643. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 9, 2024. This trademark is owned by ITALFARMACO S.p.A.. The UVIKTOS trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
uviktos

General Information


Serial Number97342643
Word MarkUVIKTOS
Filing DateFriday, April 1, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Goods and ServicesBiochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
Translation of Words in MarkThe wording "UVIKTOS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameITALFARMACO S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMilano 20126
IT

Party NameITALFARMACO S.p.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMilano 20126
IT

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022NEW APPLICATION ENTERED
Wednesday, April 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Friday, January 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2023SOU EXTENSION 1 FILED
Tuesday, May 23, 2023SOU EXTENSION 1 GRANTED
Thursday, May 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024SOU EXTENSION 2 FILED
Thursday, April 11, 2024SOU EXTENSION 2 GRANTED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED